SynthesisCancer medicine2023

Effectiveness and safety of CD22 and CD19 dual-targeting chimeric antigen receptor T-cell therapy in patients with relapsed or refractory B-cell malignancies: A meta-analysis.

Thi Thuy Nguyen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.